Ipsen
The changes set to disrupt biopharma manufacturing in 2020
July 23 by Pharma IQWe speak to Elanco, Bayer, Janssen and Ipsen to find out what they think will be the biggest changes in the industry over the next year
A quick guide to building strong relationships with your CMO
April 16 by Pharmaceuticals & Biotechnology EditorIpsen, ACINO and Bayer share insights on building superior partnerships and ensuring agility and flexibility
Inspiration Biopharmaceuticals and Ipsen Expand their Partnership in Preparation for the Commercial Launch of Inspiration’s Hemophilia Pipeline in Europe
August 30 by Pharma IQ NewsAgreement establishes European commercial partnership, leveraging Ipsen’s pan-European presence and infrastructure MAA filing in Europe for IB1001, potentially the second recombinant FIX pro...
Joël Richard VP, Peptides for Ipsen on Formulation Challenges for Biological Drug Products
April 19 by Joël RichardIn this industry interview Joël Richard Vice President, Peptides for Ipsen, speaks to Andrea Charles from Pharma IQ, about formulation challenges for biological drug products. Pharma IQ: Can...